These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 24936255)

  • 1. Clinical therapeutic strategies for early stage of diabetic kidney disease.
    Kitada M; Kanasaki K; Koya D
    World J Diabetes; 2014 Jun; 5(3):342-56. PubMed ID: 24936255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic management of diabetic kidney disease.
    Koya D; Araki S; Haneda M
    J Diabetes Investig; 2011 Aug; 2(4):248-54. PubMed ID: 24843492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnosis and management of diabetic nephropathy].
    Kitada M; Koya D
    Nihon Rinsho; 2015 Dec; 73(12):2037-43. PubMed ID: 26666150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials.
    Fernández Fernández B; Elewa U; Sánchez-Niño MD; Rojas-Rivera JE; Martin-Cleary C; Egido J; Ortiz A
    Minerva Med; 2012 Aug; 103(4):219-34. PubMed ID: 22805616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update of pathophysiology and management of diabetic kidney disease.
    Lin YC; Chang YH; Yang SY; Wu KD; Chu TS
    J Formos Med Assoc; 2018 Aug; 117(8):662-675. PubMed ID: 29486908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review on urine albumin testing for early detection of diabetic complications.
    Newman DJ; Mattock MB; Dawnay AB; Kerry S; McGuire A; Yaqoob M; Hitman GA; Hawke C
    Health Technol Assess; 2005 Aug; 9(30):iii-vi, xiii-163. PubMed ID: 16095545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
    Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic Kidney Disease: Challenges, Advances, and Opportunities.
    Chen Y; Lee K; Ni Z; He JC
    Kidney Dis (Basel); 2020 Jul; 6(4):215-225. PubMed ID: 32903946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of reducing microalbuminuria in patients with type 2 diabetes mellitus.
    Araki S; Haneda M; Koya D; Kashiwagi A; Uzu T; Kikkawa R
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S54-8. PubMed ID: 18947896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic Kidney Disease.
    Bonner R; Albajrami O; Hudspeth J; Upadhyay A
    Prim Care; 2020 Dec; 47(4):645-659. PubMed ID: 33121634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic kidney disease in pediatric patients: A current review.
    Muntean C; Starcea IM; Banescu C
    World J Diabetes; 2022 Aug; 13(8):587-599. PubMed ID: 36159227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal effects of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes and renal impairment.
    Weir MR
    Postgrad Med; 2019 Aug; 131(6):367-375. PubMed ID: 31132013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on diagnosis, pathophysiology, and management of diabetic kidney disease.
    Sugahara M; Pak WLW; Tanaka T; Tang SCW; Nangaku M
    Nephrology (Carlton); 2021 Jun; 26(6):491-500. PubMed ID: 33550672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD.
    de Sá JR; Rangel EB; Canani LH; Bauer AC; Escott GM; Zelmanovitz T; Bertoluci MC; Silveiro SP
    Diabetol Metab Syndr; 2022 Jun; 14(1):81. PubMed ID: 35690830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiologic mechanisms in diabetic kidney disease: A focus on current and future therapeutic targets.
    Barrera-Chimal J; Jaisser F
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():16-31. PubMed ID: 32267077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the Self-management Support System DialBetesPlus for Diabetic Kidney Disease: Protocol for a Randomized Controlled Trial.
    Kawai Y; Sankoda A; Waki K; Miyake K; Hayashi A; Mieno M; Wakui H; Tsurutani Y; Saito J; Hirawa N; Yamakawa T; Komiya S; Isogawa A; Satoh S; Minami T; Osada U; Iwamoto T; Takano T; Terauchi Y; Tamura K; Yamauchi T; Kadowaki T; Nangaku M; Kashihara N; Ohe K
    JMIR Res Protoc; 2021 Aug; 10(8):e31061. PubMed ID: 34402802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic kidney disease treatment: new perspectives.
    Tong LL; Adler SG
    Kidney Res Clin Pract; 2022 Sep; 41(Suppl 2):S63-S73. PubMed ID: 36239062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.